These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 11402322)

  • 1. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3.
    Yin Z; Spitz MR; Babaian RJ; Strom SS; Troncoso P; Kagan J
    Oncogene; 1999 Dec; 18(52):7576-83. PubMed ID: 10602517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC.
    Lassus H; Salovaara R; Aaltonen LA; Butzow R
    Am J Pathol; 2001 Jul; 159(1):35-42. PubMed ID: 11438451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma.
    Takebayashi S; Ogawa T; Jung KY; Muallem A; Mineta H; Fisher SG; Grenman R; Carey TE
    Cancer Res; 2000 Jul; 60(13):3397-403. PubMed ID: 10910046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
    Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of multiple incontiguous deleted regions at the long arm of chromosome 18 in head and neck cancer.
    Papadimitrakopoulou VA; Oh Y; El-Naggar A; Izzo J; Clayman G; Mao L
    Clin Cancer Res; 1998 Mar; 4(3):539-44. PubMed ID: 9533520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel tumor suppressor locus on chromosome 18q involved in the development of human lung cancer.
    Takei K; Kohno T; Hamada K; Takita J; Noguchi M; Matsuno Y; Hirohashi S; Uezato H; Yokota J
    Cancer Res; 1998 Aug; 58(16):3700-5. PubMed ID: 9721881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous deletions at 8p22 and 8p21 in prostate cancer implicate these regions as the sites for candidate tumor suppressor genes.
    Kagan J; Stein J; Babaian RJ; Joe YS; Pisters LL; Glassman AB; von Eschenbach AC; Troncoso P
    Oncogene; 1995 Nov; 11(10):2121-6. PubMed ID: 7478532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of Smad4 in gastric carcinomas.
    Powell SM; Harper JC; Hamilton SR; Robinson CR; Cummings OW
    Cancer Res; 1997 Oct; 57(19):4221-4. PubMed ID: 9331080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Status of the DPC4 tumor suppressor gene in sporadic colon adenocarcinoma of Croatian patients: identification of a novel somatic mutation.
    Popović Hadzija M; Radosevic S; Kovacević D; Lukac J; Hadzija M; Spaventi R; Pavelić K; Kapitanović S
    Mutat Res; 2004 Apr; 548(1-2):61-73. PubMed ID: 15063137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
    Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
    Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: identification of three independent regions.
    Latil A; Cussenot O; Fournier G; Driouch K; Lidereau R
    Cancer Res; 1997 Mar; 57(6):1058-62. PubMed ID: 9067271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
    Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
    Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
    MacGrogan D; Pegram M; Slamon D; Bookstein R
    Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
    Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
    Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
    Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
    Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.